US 12,297,564 B2
Quality control reagents and methods for serum antibody profiling
Kathryn Vinaya Louise Kamath, Santa Barbara, CA (US); Jack Ryan Reifert, Santa Barbara, CA (US); and Patrick Sean Daugherty, Goleta, CA (US)
Assigned to Serimmune Inc., Goleta, CA (US)
Appl. No. 17/267,004
Filed by Serimmune Inc., Goleta, CA (US)
PCT Filed Aug. 8, 2019, PCT No. PCT/US2019/045650
§ 371(c)(1), (2) Date Feb. 8, 2021,
PCT Pub. No. WO2020/033642, PCT Pub. Date Feb. 13, 2020.
Claims priority of provisional application 62/716,099, filed on Aug. 8, 2018.
Prior Publication US 2021/0230580 A1, Jul. 29, 2021
Int. Cl. C40B 40/10 (2006.01); C12N 15/10 (2006.01); C40B 40/08 (2006.01)
CPC C40B 40/08 (2013.01) [C12N 15/1037 (2013.01); C12N 15/1072 (2013.01)] 30 Claims
OG exemplary drawing
 
1. A peptide expression library composition comprising:
a) a library of nucleic acid sequences encoding a library of peptides;
b) one or more control vectors comprising:
1) A nucleic acid sequence encoding a control binding target of a control binding molecule, wherein the control binding target is identical for each of the control vectors, and
2) A unique nucleic acid sequence, wherein the unique nucleic acid sequence is specific for each of the control vectors.